Navigation Links
The AACR commends Senators Kennedy and Hutchison on the 21st Century Cancer ALERT Act
Date:3/26/2009

PHILADELPHIA ― On Thursday, Senators Edward M. Kennedy and Kay Bailey Hutchison introduced legislation that will renew the war on cancer by modernizing and advancing the national cancer program of the United States.

The 21st Century Cancer ALERT (Access to Life-saving Early detection, Research and Treatment) Act represents an important effort to re-assess the national cancer program and improve cancer research, prevention, detection, control and treatment in the United States. The legislation aims to expand and accelerate the search for cures, more effective treatments and better preventive measures while addressing the ongoing needs of the nearly 12 million Americans struggling with cancer today.

"It is imperative that we move with greater speed to strengthen and expand our nation's efforts to prevent, treat and cure cancer," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research. "The leadership that Senators Kennedy and Hutchison are providing comes at a pivotal moment, when decades of scientific effort are converging to produce a revolution in cancer research and care. The 21st Century Cancer ALERT Act represents a critical step in modernizing the national cancer program and in improving our ability to make headway in the war on cancer."

Since the United States declared war on cancer over four decades ago with the signing of National Cancer Act of 1971, tremendous strides have been made in the understanding of the disease and in the development of therapies that have increased survival and improved the lives of millions. Despite these accomplishments, cancer still kills more than 560,000 Americans each year. Without a greater commitment to cancer research, this number will increase as the baby boom generation grows older. In fact, by 2010, cancer will be the world's number one killer, according to the World Health Organization.

In their endeavor to address the complexities and obstacles confronting the national cancer program, Senators Kennedy and Hutchison have sought input from stakeholders representing every aspect of cancer research and care from the bench to bedside. The AACR applauds their leadership in engaging a wide range of experts to identify key challenges and craft legislation that presents solutions that will foster a new age of discovery and patient care.

"The AACR has been grateful for the opportunity to contribute its expertise in cancer research to this undertaking," said Ray DuBois, M.D., Ph.D., president of the American Association for Cancer Research and provost and executive vice president of The University of Texas M. D. Anderson Cancer Center. "We look forward to working closely with Senators Kennedy and Hutchison to refine this legislation and advance it quickly through Congress for the benefit of cancer patients and their families."


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation
2. Illinois Hospital Association Commends Governor for Protecting Health Care in State Budget Proposal
3. The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring Common Sense Legislation Widely Hailed as Good for Patients, Good for Taxpayers, Good for Florida
4. Virtua Commends Gov. Corzines Charity Care Funding Plan
5. National Multiple Sclerosis Society Commends President Obamas Initial Steps in Removing the Bans on Embryonic Stem Cell Research
6. Christopher & Dana Reeve Foundation Commends President Obamas Decision to Lift Federal Restrictions on Stem Cell Research
7. Save Abandoned Babies Foundation Commends Illinois Hospitals for Being 100% in Compliance in Displaying Safe Haven Signs
8. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
9. NACDS Commends Obama's Shared Commitment on Accessible, Quality and Affordable Healthcare
10. Himfr.com Recommends Five Foods for Spring
11. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the United ... persecution, Center for Medicine after the Holocaust (CMATH) announced that it will ... and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany and ...
(Date:4/24/2017)... ... , ... Today, Bright Pink , a national non-profit organization focusing on the prevention and ... , Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. ... as Chairman of the Board and launched a national search to find a visionary ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
(Date:4/24/2017)... ... 2017 , ... The world-class designers of Happy Gadget Alert ... lifesaving device for the everyday use of parents worldwide. It is a lightweight, ... a child’s vital signs, and detect unusual symptoms or physical patterns. This innovative ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: